• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切除肝脏对肝癌患者循环肿瘤细胞的影响。

Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma.

机构信息

Translational Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.

Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出版信息

BMC Cancer. 2018 Aug 20;18(1):835. doi: 10.1186/s12885-018-4744-4.

DOI:10.1186/s12885-018-4744-4
PMID:30126375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6102841/
Abstract

BACKGROUND

This study explored the effect of liver resection on perioperative circulating tumor cells (CTCs) and found that the prognostic significance of surgery was associated with changes in CTC counts in patients with hepatocellular carcinoma (HCC).

METHODS

One hundred thirty-nine patients with HCC were consecutively enrolled. The time-points for collecting blood were one day before operation and three days after operation. CTCs in the peripheral blood were detected by the CellSearch™ System.

RESULTS

Both CTC detection incidence and mean CTC counts showed greater increases postoperatively (54%, mean 1.54 cells) than preoperatively (43%, mean 1.13 cells). The postoperative CTC counts increased in 41.7% of patients, decreased in 25.2% of patients and did not change in 33.1% of patients. The increase in postoperative CTC counts was significantly associated with the macroscopic tumor thrombus status. Patients with increased postoperative CTC counts (from preoperative CTC < 2 to postoperative CTC ≥ 2) had significantly shorter disease-free survival (DFS) and overall survival (OS) than did patients with persistent CTC < 2. Patients with persistent CTC levels of ≥2 had the worst prognoses.

CONCLUSIONS

Surgical liver resection is associated with an increase in CTC counts, and increased postoperative CTC numbers are associated with a worse prognosis in patients with HCC.

摘要

背景

本研究探讨了肝切除术对围手术期循环肿瘤细胞(CTC)的影响,发现手术的预后意义与肝癌(HCC)患者 CTC 计数的变化相关。

方法

连续纳入 139 例 HCC 患者。采集血液的时间点为术前一天和术后三天。外周血中的 CTCs 通过 CellSearch™系统检测。

结果

术后 CTC 检测发生率和平均 CTC 计数均高于术前(54%,平均 1.54 个细胞;43%,平均 1.13 个细胞)。术后 41.7%的患者 CTC 计数增加,25.2%的患者 CTC 计数减少,33.1%的患者 CTC 计数无变化。术后 CTC 计数的增加与肿瘤栓子的宏观状态显著相关。与持续 CTC<2 的患者相比,术后 CTC 计数增加(从术前 CTC<2 到术后 CTC≥2)的患者无病生存率(DFS)和总生存率(OS)显著缩短。持续 CTC 水平≥2 的患者预后最差。

结论

手术切除肝脏与 CTC 计数的增加相关,术后 CTC 数量的增加与 HCC 患者的预后较差相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c44/6102841/12f287e04b06/12885_2018_4744_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c44/6102841/cbe2978e7649/12885_2018_4744_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c44/6102841/52f6651913ac/12885_2018_4744_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c44/6102841/12f287e04b06/12885_2018_4744_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c44/6102841/cbe2978e7649/12885_2018_4744_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c44/6102841/52f6651913ac/12885_2018_4744_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c44/6102841/12f287e04b06/12885_2018_4744_Fig3_HTML.jpg

相似文献

1
Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma.手术切除肝脏对肝癌患者循环肿瘤细胞的影响。
BMC Cancer. 2018 Aug 20;18(1):835. doi: 10.1186/s12885-018-4744-4.
2
Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.术前上皮细胞黏附分子循环肿瘤细胞及外周调节性T细胞水平与肝癌根治性肝切除术后早期复发的相关性
BMC Cancer. 2016 Jul 20;16:506. doi: 10.1186/s12885-016-2526-4.
3
Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.术前循环肿瘤细胞预测微血管侵犯和动态检测可预测肝细胞癌的预后。
BMC Cancer. 2020 Oct 31;20(1):1047. doi: 10.1186/s12885-020-07488-8.
4
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.EpCAM 阳性循环肿瘤细胞作为生物标志物存在与肝细胞癌患者的系统性疾病和生存密切相关。
Int J Cancer. 2013 Nov;133(9):2165-71. doi: 10.1002/ijc.28230. Epub 2013 Jun 11.
5
Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection.术后循环肿瘤细胞:行根治性手术切除的肝细胞癌患者发生肝外转移的早期预测指标。
Cancer Cytopathol. 2020 Oct;128(10):733-745. doi: 10.1002/cncy.22304. Epub 2020 Jun 5.
6
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.循环干细胞样上皮细胞黏附分子阳性肿瘤细胞预示肝癌根治性切除术后不良预后。
Hepatology. 2013 Apr;57(4):1458-68. doi: 10.1002/hep.26151. Epub 2013 Mar 4.
7
Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma.围手术期循环肿瘤干细胞标志物表达增加预示肝细胞癌根治性切除术后早期复发
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1444-52. doi: 10.1245/s10434-015-4480-9. Epub 2015 Mar 20.
8
Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.术前天冬氨酸转氨酶与中性粒细胞比值指数对肝癌肝切除术后患者的预后意义
Oncotarget. 2016 Nov 1;7(44):72276-72289. doi: 10.18632/oncotarget.10848.
9
High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.高上皮细胞粘附分子阳性循环肿瘤细胞计数预示经动脉化疗栓塞治疗的不可切除肝细胞癌患者生存预后不良。
J Vasc Interv Radiol. 2018 Dec;29(12):1678-1684. doi: 10.1016/j.jvir.2018.07.030. Epub 2018 Nov 2.
10
Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.肝细胞癌手术切除后肝细胞和肿瘤细胞的血行播散:定量分析
Clin Cancer Res. 1999 Dec;5(12):4021-7.

引用本文的文献

1
Association between Vessels Encapsulating Tumor Clusters and Circulating Tumor Cells in Hepatocellular Carcinoma: Clinical Evidence and Risk Model Development.肝细胞癌中包裹肿瘤细胞簇的血管与循环肿瘤细胞之间的关联:临床证据及风险模型构建
Int J Med Sci. 2025 Jun 12;22(12):2944-2955. doi: 10.7150/ijms.111025. eCollection 2025.
2
Role of Liquid Biopsy for Early Detection, Prognosis, and Therapeutic Monitoring of Hepatocellular Carcinoma.液体活检在肝细胞癌早期检测、预后评估及治疗监测中的作用
Diagnostics (Basel). 2025 Jun 28;15(13):1655. doi: 10.3390/diagnostics15131655.
3
Liver transplantation for malignant liver tumors.

本文引用的文献

1
Surgery for Cancer: A Trigger for Metastases.癌症手术:转移的诱因
Cancer Res. 2017 Apr 1;77(7):1548-1552. doi: 10.1158/0008-5472.CAN-16-1536. Epub 2017 Mar 22.
2
Perioperative circulating tumor cell detection: Current perspectives.围手术期循环肿瘤细胞检测:当前观点
Cancer Biol Ther. 2016 Aug 2;17(8):859-69. doi: 10.1080/15384047.2016.1167296. Epub 2016 Apr 5.
3
Comparison of Two Types of Liquid Biopsies in Patients With Hepatocellular Carcinoma Awaiting Orthotopic Liver Transplantation.等待原位肝移植的肝细胞癌患者两种液体活检类型的比较
恶性肝肿瘤的肝移植
ILIVER. 2022 Apr 18;1(1):3-11. doi: 10.1016/j.iliver.2022.04.002. eCollection 2022 Mar.
4
Preoperative circulating tumor cells indicate microvascular invasion and dynamical detection indicate the early recurrence of hepatocellular carcinoma.术前循环肿瘤细胞提示微血管侵犯,动态检测提示肝细胞癌早期复发。
BMC Cancer. 2025 Jul 1;25(1):1025. doi: 10.1186/s12885-025-14178-w.
5
Liquid Biopsy in Hepatocellular Carcinoma: ctDNA as a Potential Biomarker for Diagnosis and Prognosis.肝细胞癌中的液体活检:循环肿瘤DNA作为诊断和预后的潜在生物标志物
Curr Oncol Rep. 2025 May 9. doi: 10.1007/s11912-025-01681-3.
6
Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma.埃兹蛋白极化作为肝细胞癌循环肿瘤细胞的诊断标志物
Cells. 2024 Dec 25;14(1):6. doi: 10.3390/cells14010006.
7
Exploring Circulating Tumor Cells: Detection Methods and Biomarkers for Clinical Evaluation in Hepatocellular Carcinoma.探索循环肿瘤细胞:肝细胞癌临床评估的检测方法与生物标志物
J Clin Transl Hepatol. 2024 Dec 28;12(12):1020-1042. doi: 10.14218/JCTH.2024.00230. Epub 2024 Oct 17.
8
Improving the Prognostic and Predictive Value of Circulating Tumor Cell Enumeration: Is Longitudinal Monitoring the Answer?提高循环肿瘤细胞计数的预后和预测价值:纵向监测是答案吗?
Int J Mol Sci. 2024 Oct 2;25(19):10612. doi: 10.3390/ijms251910612.
9
Prognostic prediction signature and molecular subtype for liver cancer: A CTC/CTM‑related gene prediction model and independent external validation.肝癌的预后预测特征及分子亚型:一种与循环肿瘤细胞/循环肿瘤微栓相关的基因预测模型及独立外部验证
Oncol Lett. 2024 Sep 3;28(5):531. doi: 10.3892/ol.2024.14664. eCollection 2024 Nov.
10
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma.用于肝细胞癌诊断和治疗选择的生物标志物。
Mol Cancer. 2024 Sep 6;23(1):189. doi: 10.1186/s12943-024-02101-z.
Transplant Proc. 2015 Nov;47(9):2639-42. doi: 10.1016/j.transproceed.2015.10.003.
4
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma.循环肿瘤细胞与胆管癌患者的总体生存率低相关。
Hepatology. 2016 Jan;63(1):148-58. doi: 10.1002/hep.27944. Epub 2015 Aug 7.
5
Localized and systemic approaches to treating hepatocellular carcinoma.治疗肝细胞癌的局部和全身方法。
J Clin Oncol. 2015 Jun 1;33(16):1835-44. doi: 10.1200/JCO.2014.60.1153. Epub 2015 Apr 27.
6
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.肝细胞癌中的循环肿瘤细胞:病例与对照的检测、计数及二代测序的初步研究
BMC Cancer. 2015 Mar 31;15:206. doi: 10.1186/s12885-015-1195-z.
7
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
8
Exploiting the critical perioperative period to improve long-term cancer outcomes.利用围手术期关键时期改善癌症长期预后。
Nat Rev Clin Oncol. 2015 Apr;12(4):213-26. doi: 10.1038/nrclinonc.2014.224. Epub 2015 Jan 20.
9
Circulating biomarkers in hepatocellular carcinoma.肝细胞癌的循环生物标志物。
Cancer Chemother Pharmacol. 2014 Aug;74(2):323-32. doi: 10.1007/s00280-014-2508-7. Epub 2014 Jun 13.
10
Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry.通过半定量免疫细胞化学鉴定肝细胞癌生物标志物
World J Gastroenterol. 2014 May 21;20(19):5826-38. doi: 10.3748/wjg.v20.i19.5826.